Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy

OBJECTIVE: This study aimed to determine the prognostic factors of progression-free survival (PFS) and overall survival (OS) in non-nephrectomized patients with synchronous metastatic renal cell carcinoma (mRCC) receiving first-line vascular endothelial growth factor (VEGF)-targeted therapy or immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Han, Kim, Jung Kwon, Park, Eun Young, Joo, Jungnam, Lee, Kang Hyun, Seo, Ho Kyung, Joung, Jae Young, Chung, Jinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382149/
https://www.ncbi.nlm.nih.gov/pubmed/30785902
http://dx.doi.org/10.1371/journal.pone.0211105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382149/
https://www.ncbi.nlm.nih.gov/pubmed/30785902
http://dx.doi.org/10.1371/journal.pone.0211105

Ejemplares similares